FDA meeting

The FDA hosted representatives of the healthcare industry for the Summer DSCSA meeting on August 23rd. 2017.  This article is RXTransparent’s summary of the meeting and represents  our opinion and our opinion only.  As with previous RXTransparent publications,...

How does the enforcement delay impact DSCSA?

  The FDA announced that the agency “Does not intend to take action against manufacturers who do not, prior to November 26, 2018, affix or imprint a product identifier to each package and homogeneous case of product intended to be introduced in a transaction into...